Navigation Links
PAP-4D

ProductsPAP-4D
Company Bio/Data Corporation
Item PAP-4D
Features Von willebrand assay (Ristocetin cofactor): calculates and plots "best fit" standard curve, reports test results in percent activity, stores von willebrand factor standard curve for future use, prints data on log-log chart. Platelet aggregation: four channels allow simultaneous performance of a routine aggregation profile, automatic 0% - 100% baseline settings, reports slope value and final percent aggregation, prints aggregation patterns in real time. Leukocyte aggregation: adjustable stir speed settings meet method-specific RPM requirements, convenient four channel setup for dose response studies of chemotactic stimuli or pharmaceutical agents, provides percent transmission for cell suspension standardization, maintains optimum temperature for cell viability and reactivity. Data interface system. Heparin Induced Platelet Aggregation (HIPA) for Heparin-Induced Thrombocytopenia (HIT).
Description The PAP-4D is a four channel Platelet Aggregation Profiler combined with a stand alone data system. Operating in conjunction with Microsoft Windows, the PAP-4D has real time, four color display of tests, automatic storage of test results, plus simplified data retrieval and data management. Three test modes are available: von willebrand assay (Ristocetin cofactor), platelet aggregation and leukocyte aggregation. The PAP-4D may also be used for the evaluation and confirmation of Heparin Induced Thrombocytopenia (HIT). Four channels allow four tests to be run simultaneously and independently. Select standard volumes or microvolume quantities to reduce sample and reagent consumption.
Info Bio/Data Corporation
Customer Service: (800) 257-3282
Web site: http://www.biodatacorp.com/

Related medicine products :

1. PAP-4CD
... molecular weight of 16 kDa. Leptin is a ... adipocytes [1,2]. Leptin is thought to play a ... In the human, leptin levels are elevated with ... A relationship between serum leptin levels and several measures ...
... a molecular weight of 16 kDa. Leptin is ... by adipocytes [1,2]. Leptin is thought to play ... [1-3]. In the human, leptin levels are elevated ... A relationship between serum leptin levels and several ...
ACTIVATED CLOTTING TIME SYSTEM...
... Compact CT is a completely ... of performing clotting assays in ... unique method of sample management ... processing of STAT samples without ...
Medicine Products:
(Date:4/28/2017)... ... April 28, 2017 , ... Somnoware, a ... Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to create and edit their interpretation ... process and provides a familiar interface that does not require additional training to ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... http://www.foodsthathealdaily.com , http://www.wiredlifesolutions.com , “Computers are everywhere and they’re here to ... of Water, Global Climate Change and Your Health on Voice America sponsored by ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Texas Cord Blood Bank (TCBB), a program ... delivery team at Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in ... and decide to donate. , “Women’s Hospital at Renaissance has been a collection ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... which name the Creator responds to and which He does not. Yisrayl says with ... which one is the true name, but he says with a little Scripture, backed with ...
(Date:4/28/2017)... ... 28, 2017 , ... NuevaCare, a leading home care agency based in San ... Alto, is proud to announce information upgrades to its blog in the form of ... on topics such as home care (generally) as well as senior care and home ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  Vanderbilt University Medical ... patients in Nashville , Tennesse have ... Esophageal Sphincter Stimulation for GERD (LESS GERD) trial. The ... provide long-term reflux control by restoring normal function to ... 65 million people in the United States ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
(Date:4/19/2017)... 2017  New research provides evidence that an old drug ... a study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... Parkinson,s disease, the oral drug levodopa has long been considered ... as the disease progresses, the effects of the medication can ...
Breaking Medicine Technology: